Celgene

New Jersey, United States – Verified Market Research recently released a research report titled “Global Isocitrate Dehydrogenase Inhibitors Market Insight, Forecast.” The report extensively discusses the Global Isocitrate Dehydrogenase Inhibitors market, offering readers a comprehensive understanding of key trends, top strategies, and potential growth opportunities. It incorporates Porter’s Five Forces analysis, PESTEL analysis, as well as…

New Jersey, United States – The Global Alpha Thalassemia Treatment market is projected to experience significant growth, as per the latest research report by Verified Market Research titled “Global Alpha Thalassemia Treatment Market Insights, Forecast to 2030.” The report presents a unique perspective on the global market. Analysts anticipate that changing consumption patterns will greatly impact…

Teva’s CEO Richard Francis is adding to his constellation of new executives with a fresh business development hire from BeiGene. | Teva has enlisted BeiGene's Angus Grant, Ph.D. as its EVP of business development, the Israeli-American generics giant announced Friday. It was during Grant's tenure as chief business executive that BeiGene signed the high-profile PD-1…

As per the study initiated by Evolve Business Intelligence, the global Cancer Therapy Market size accounted for USD 98.5 Billion in 2022, growing at a CAGR of 7.7% from 2023 to 2033. The Cancer Therapy Market refers to the global market for products and services used in the treatment and management of cancer. Cancer therapy…

For Immediate Release Chicago, IL – July 21, 2023 – Zacks Equity Research shares Cadence Design Systems CDNS as the Bull of the Day and Ligand Pharmaceuticals LGND as the Bear of the Day. In addition, Zacks Equity Research provides analysis on The Boeing Company BA, L3Harris Technologies LHX and Embraer SA ERJ. Here is…

In this third installment of a six-part Patent Law Course offered by Morrison & Foerster and GSAS Harvard Biotech Club, MoFo partner and head of the firm’s China Life Sciences Group Janet Xiao taught a class on the value, protection, and legal issues involved with biotechnology patents, as well as a comparison between generics and biogenerics. ‘The students were…

The Acute Lymphocytic-Lymphoblastic Leukemia (ALL) Therapeutics Market provides in-depth analysis of global, regional and country-level markets, segmentation growth, market share, competitive landscape, sales analysis, impact of global and domestic Acute Lymphocytic-Lymphoblastic Leukemia (ALL) Therapeutics Market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, expanding areas of the market, and…

JHVEPhoto Pfizer Inc. (NYSE:PFE ) investors have likely been baffled by the market's battering as it fell toward lows last seen in early 2021. I gleaned that dip buyers attempted a mean-reversion opportunity in May 2023 but were rejected by sellers. Given the relative underperformance of PFE and its healthcare peers ( XLV), underlying sector…

A U.S. District Court on Wednesday tossed a lawsuit in which Bristol Myers Squibb (BMY) was accused of fraud over $6.4B payout linked to its Celgene acquisition. Read the full story here.

Nucleai, a leader in AI-powered spatial biology, today announced the two key appointments to its leadership team and scientific advisory board. Pharma

Did Bristol Myers Squibb deliberately drag its feet with Breyanzi’s FDA application to avoid paying former Celgene shareholders $6.4 billion? A federal judge found no proof of that intent. | Did Bristol Myers Squibb deliberately dragged its feet with Breyanzi’s FDA application to avoid paying former Celgene shareholders $6.4 billion? A federal judge found no…

Sun Pharmaceutical Industries on Friday said its subsidiary has received approval from the US health regulator to market a generic medication used in the treatment of multiple myeloma. The company has received final approval from the US Food and Drug Administration (USFDA) for the generic lenalidomide capsules in multiple strengths, Sun Pharma said in a…